Preclinical characterization of TGRX-678, a brain-penetrant allosteric inhibitor of BCR::ABL1. Shi Y, Jiang Q, Li L, Zuo Y, et al. Blood 2025;146:2088-2101.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shi Y, Jiang Q, Li L, Zuo Y, et al. Preclinical characterization of TGRX-678, a brain-penetrant allosteric inhibitor of BCR::ABL1. Blood 2025;146:2088-2101.
PMID: 40700636